Q1 earnings miss sparks 8% YTD drop
HCA Healthcare reported Q1 2026 EPS of $7.15, lacking estimates by $0.04 on April 24. Shares down 8.2% YTD to $428, with analysts seeing 21% upside to $518 goal.
HCA Healthcare launched its Q1 2026 earnings on April 24, 2026, posting EPS of $7.15, which fell wanting the $7.19 consensus estimate by $0.04, MarketBeat as of April 24, 2026. The inventory has declined 8.2% year-to-date, buying and selling at $428.01 on May 14, 2026, down from $466.49 on January 1, 2026, MarketBeat as of May 14, 2026. Analysts keep a Moderate Buy score with a $517.82 worth goal, implying 21% upside.
As of: 05/14/2026
By the editorial group – specialised in fairness protection.
At a look
- Yam: HCA Healthcare, Inc.
- Sector/trade: Healthcare suppliers
- Headquarters/nation: Nashville, Tennessee, USA
- Core markets: United States
- Key income drivers: Hospital operations, inpatient/outpatient companies
- Home alternate/itemizing venue: NYSE (HCA)
- Trading forex: USD
HCA Healthcare: core enterprise mannequin
HCA Healthcare operates one of many largest hospital networks within the US, managing over 180 hospitals and a pair of,400 care websites throughout 20 states. The firm focuses on acute care, surgical procedures, and emergency companies, producing income primarily from affected person charges coated by authorities applications akin to Medicare and Medicaid in addition to business insurance coverage. This mannequin advantages from regular US healthcare demand pushed by an growing older inhabitants.
For US buyers, HCA Healthcare affords publicity to the resilient $4 trillion US healthcare sector, the place hospital operators maintain vital market share amid rising process volumes.
Main income and product drivers for HCA Healthcare
Inpatient and outpatient companies account for the majority of income, with This autumn 2025 EPS at $8.14, up from $5.63 year-over-year, per StockStory as of 2026. The firm has repurchased shares aggressively, lowering share rely by 34% over 5 years, boosting EPS progress past income positive factors. Key drivers embrace elective surgical procedures and emergency care, which rebounded post-pandemic.
Admissions and equal metrics stay core, with US market dominance offering scale benefits in negotiations with insurers.
Conclusion
HCA Healthcare’s Q1 earnings miss highlights pressures within the US hospital sector, but aggressive buybacks and a robust analyst consensus sign confidence in its operational scale. Shares have pulled again YTD, buying and selling beneath the $518 goal amid broader market dynamics. Investors observe upcoming quarters for quantity restoration and margin developments on this important healthcare play.
Disclaimer: This article doesn’t represent funding recommendation. Stocks are risky monetary devices.
